Skip To Main Content

Transplantační medicína

Nejnovější trendy

Prozkoumejte nejčtenější články a videa na Campus Sanofi

Seřadit

Bedienungsanleitung zum Sanofi-Webshop

Event one: What next for COPD?
Biomarkers, phenotypes, endotypes, and targeted treatment

Recorded on 24 March at TSANZSRS 2025 ASM

COPD phenotyping and biomarkers

What kind of COPD does my patient have? Applying phenotypes in practice  

EAS 2025 : Αναγνώριση και Διαχείριση του ασθενούς πριν από το Οξύ Στεφανιαίο Σύμβαμα

Videoreportáž EHA Milano

Webinar On-Demand: Optimizing the Type 2 Diabetes Patient Journey with Fixed-Ratio Combinations

Sanofi-sponsored symposium originally presented at SEMDSA 2025, now available on-demand. In this engaging session, leading experts delve into the critical decision points along the Type 2 Diabetes patient journey and the evolving role of Fixed-Ratio Combination (FRC) therapies. Explore real-world patient challenges and gain a deeper understanding of how FRCs can simplify treatment, improve adherence, and support better outcomes. The session also features a comparative analysis of the latest efficacy and safety data on iGlarLixi (insulin glargine/lixisenatide) versus iDegAsp (insulin degludec/aspart) in non-Asian populations—shedding light on practical considerations for clinical use.

Záznam ze sympozia - "Příhoda není náhoda, nečekejme na ni"

Záznam ze sympozia - "Proč nevyužíváme potenciál hypolipidemické léčby ani u rizikových pacientů?"

Ukryty wpływ skumulowanego upośledzenia przebiegu życia (CLCI) w dermatologii: Wprowadzenie

Personalizing Antiplatelet Therapy: Insights for High-Risk PCI Patients

REZUROCK®: Experiencia clínica en seguridad para EICHc

European Academy of Allergy and Clinical Immunology (EAACI) Congress Highlights

13–16 June 2025, in Glasgow, Scotland.